Trials / Completed
CompletedNCT06095544
Enhanced Recovery After Surgery for SPK Transplantation Recipients
A Clinical Study on the Application of Enhanced Recovery After Surgery for Simultaneous Pancreas-kidney Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University · Academic / Other
- Sex
- All
- Age
- 20 Years – 62 Years
- Healthy volunteers
- Accepted
Summary
108 patients underwent elective SPK surgery were randomly divided into ERAS group (E) and routine care group (T). The ERAS group was consisted of evidenced-based systematic optimization approaches, while the control group received routine care.
Detailed description
Primary results: the postoperative length of stay (LoS) and hospitalization costs; second results: post-operative analgesia score (NRS) , the incidence of post-operative nausea and vomiting (PONV) , urinary catheter removal time by 7 days , post-operative gastric tube indwelling time, the incidence of ambulation within 6 days . the dosage of dobutamine using , the dosage of norepinephrine using, and the total amount of fluid and urine volume . MAP and lactate level . Peak systolic velocity (PSV) and (resistance index) RI of grafts were checked between two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Enhanced recovery for SPK recipients | Pre-operative, perioperative and post-operative were consisted of evidenced-based systematic optimization approaches. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-12-01
- Completion
- 2023-06-01
- First posted
- 2023-10-23
- Last updated
- 2023-10-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06095544. Inclusion in this directory is not an endorsement.